Steve Schonfeld’s Crescent Biopharma CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$472K Buy
+32,349
New +$542K ﹤0.01% 2001
2021
Q1
– Sell
-158
Closed -$60K – 1920
2020
Q4
$60K Buy
+158
New +$55.4K ﹤0.01% 1488
2018
Q3
– Sell
-1,400
Closed -$2.26M – 880
2018
Q2
$2.26M Sell
1,400
-996
-42% -$1.71M 0.12% 249
2018
Q1
$3.89M Sell
2,396
-2,104
-47% -$4.38M 0.29% 99
2017
Q4
$7.56M Sell
4,500
-501
-10% -$662K 0.62% 29
2017
Q3
$7M Sell
5,001
-409
-8% -$480K 0.64% 33
2017
Q2
$6.04M Buy
+5,410
New +$4.47M 0.62% 31

Other funds holding CBIO

Steve Schonfeld's CBIO Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Crescent Biopharma (CBIO) in Q3 2026: 32,349 shares worth $472K. The stake represents ﹤0.01% of the portfolio and ranks #2001 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in CBIO as recently as Q4 2020.

Steve Schonfeld first reported a position in CBIO in Q2 2017 and has held it in 7 quarters since. The position peaked at $7.56M in Q4 2017. 106 funds tracked by Wall St. Rank hold CBIO as of Q3 2026.

  • Steve Schonfeld held 32,349 shares of Crescent Biopharma worth $472K as of Q3 2026.
  • Crescent Biopharma was a new Steve Schonfeld position in Q3 2026.
  • Crescent Biopharma made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #2001 holding.
  • Steve Schonfeld first reported a position in Crescent Biopharma in Q2 2017 and has held it in 7 quarters since.
  • Steve Schonfeld's Crescent Biopharma position peaked at $7.56M in Q4 2017.
  • 106 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.